Abstract:Purpose Patients with head and neck cancer are at risk for disease- and treatment-related toxicities that may be severe enough to require hospitalization. The risk factors associated with hospitalization in these patients are not well defined. Methods We conducted a single-center, retrospective observational study of patients with head and neck cancer receiving chemotherapy at an academic medical center infusion clinic in a one-year period. The primary objective was to characterize the head and neck cancer pop… Show more
“…Alcohol dependence and abuse has been shown to be an independent risk factor of poor outcomes in head and neck cancer surgery patients. 25 In their evaluation of adult patients following oral and maxillofacial surgery, Loeffelbein et al 26 found that alcohol abuse was an independent risk factor of postoperative pulmonary complications. Alcohol dependence and abuse is associated with liver disease, and such liver pathology may increase in the risk of poor postoperative outcomes.…”
To our knowledge, this represents the first study to evaluate potential risk factors of acute respiratory failure following inpatient sinus surgery. Knowledge of these risk factors may be used for risk stratification.
“…Alcohol dependence and abuse has been shown to be an independent risk factor of poor outcomes in head and neck cancer surgery patients. 25 In their evaluation of adult patients following oral and maxillofacial surgery, Loeffelbein et al 26 found that alcohol abuse was an independent risk factor of postoperative pulmonary complications. Alcohol dependence and abuse is associated with liver disease, and such liver pathology may increase in the risk of poor postoperative outcomes.…”
To our knowledge, this represents the first study to evaluate potential risk factors of acute respiratory failure following inpatient sinus surgery. Knowledge of these risk factors may be used for risk stratification.
“…[34]. The examination by Hazelden et al, 2019, identified a few factors which might be helpful to recognize patients as high risk for hospitalization and the following stages will be to decide and consider the role of the drug specialist in preventing hospitalization of these patients [35]. However, machine learning based drug synergy prediction approaches suffer from the parameter tuning problem.…”
An efficient prediction of drug synergy plays a significant role in the medical domain. Examination of different drug-drug interaction can be achieved by considering the drug synergy score. With an rapid increase in cancer disease, it becomes difficult for doctors to predict significant amount of drug synergy. Because each cancer patient's infection level varies. Therefore, less or more amount of drug may harm these patients. Machine learning techniques are extensively used to estimate drug synergy score. However, machine learning based drug synergy prediction approaches suffer from the parameter tuning problem. To overcome this issue, in this paper, an efficient Differential evolution based multinomial random forest (DERF) is designed and implemented. Extensive experiments by considering the existing and the proposed DERF based machine learning models. The comparative analysis of DERF reveals that it outperforms existing techniques in terms of coefficient of determination, root mean squared error and accuracy.
“…2 Since the majority of patients often present with locally advanced disease, multi-modality treatment is typically required and may include surgery, radiation, and/or systemic therapy. 1,4,5 As a result, HNC treatment is associated with significant toxicities, such as severe mucositis, odynophagia, dysphagia, dehydration, emesis, and poor oral intake. 4,5 It is well established that these toxicities can become severe enough to warrant hospitalization.…”
Section: Introductionmentioning
confidence: 99%
“…1,4,5 As a result, HNC treatment is associated with significant toxicities, such as severe mucositis, odynophagia, dysphagia, dehydration, emesis, and poor oral intake. 4,5 It is well established that these toxicities can become severe enough to warrant hospitalization. 4,5 Therefore, HNC treatment necessitates a multidisciplinary approach to ensure timely and coordinated care throughout treatment.…”
Section: Introductionmentioning
confidence: 99%
“…4,5 It is well established that these toxicities can become severe enough to warrant hospitalization. 4,5 Therefore, HNC treatment necessitates a multidisciplinary approach to ensure timely and coordinated care throughout treatment. 1,3 The literature has described that early palliative care interventions in patients with advanced cancer can improve quality of life, prolong survival, and decrease social distress.…”
Introduction Head and neck cancers (HNC) are a complex and heterogeneous group of cancers, often necessitating a multidisciplinary approach across the care continuum. Oncology pharmacists are uniquely qualified to play a vital role on a multidisciplinary team and provide specialized care to optimize medication therapy. Methods This was a retrospective chart review evaluating the role of a board-certified oncology pharmacist in the head and neck oncology clinic at an academic, comprehensive cancer center from April 2017 through March 2018. The primary objective of the study was to describe the types of interventions made by the oncology pharmacists. Secondary objectives included quantifying time spent on patient education and number of prescriptions sent to pharmacies. Results The pharmacist had 873 encounters with 151 patients, resulting in 2080 interventions. Approximately 57% of the interventions were performed in the clinic. Patient education (58%), facilitation of new prescriptions or refill requests (49.9%), and supportive care management (32.6%) were the most frequent interventions. The oncology pharmacist spent 154.1 h on patient education and sent 811 prescriptions to pharmacies, with 63.6% of prescriptions sent to the institution’s cancer center pharmacy. Conclusion The incorporation of an oncology pharmacist in the HNC team optimized patient care through comprehensive and timely interventions across the care continuum. Our study is the first to highlight the vital role oncology pharmacists have in improving the overall quality of care of HNC patients. Future directions include exploring the impact of oncology pharmacist interventions on select Quality Oncology Practice Initiative measures by the American Society of Clinical Oncology.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.